Strategic partnership SpinTech has formed or announced collaborations with IMRIS to integrate STAGE software into the IMRIS InVision Surgical Theatre platform, presenting a co-sell opportunity to expand market access in intraoperative MRI settings.

Neurological focus STAGE targets critical neurological conditions such as traumatic brain injury, dementia, Parkinson's, multiple sclerosis, and stroke, aligning with high-value imaging needs and potential growth in neurology-focused hospitals and research centers.

ASR and ROI emphasis STAGE reduces scan time by about 30% and enhances visualization with biomarkers, improving patient throughput and ROI on existing MRI equipment, a compelling message for facilities looking to maximize asset utilization.

Funding validation The company’s Series A funding of 6.5M and FDA-cleared STAGE position SpinTech as a credible partner for early adopters and centers pursuing innovative imaging technologies supported by reputable financing and regulatory readiness.

Growth readiness With a recent small to mid-sized employee base and a cloud-enabled technology stack, SpinTech is poised for scalable deployments across multi-center trials and hospitals seeking advanced AI-assisted imaging without extensive hardware upgrades.